Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0079
+0.0007 (9.72%)
At close: Jun 12, 2026
Evofem Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 20.24 | 20.18 | 19.36 | 18.22 | 16.84 | 8.24 | |
Revenue Growth (YoY) | 21.87% | 4.23% | 6.29% | 8.20% | 104.23% | 1748.43% |
Cost of Revenue | 4.66 | 4.62 | 3.83 | 6.51 | 4.42 | 4.05 |
Gross Profit | 15.58 | 15.57 | 15.53 | 11.71 | 12.42 | 4.19 |
Selling, General & Admin | 16.58 | 17.08 | 20.74 | 26.74 | 71.72 | 138.36 |
Research & Development | 2.1 | -3.45 | 1.84 | 2.81 | 24.82 | 32.63 |
Amortization of Goodwill & Intangibles | 0.35 | 0.5 | 0.62 | - | - | - |
Operating Expenses | 19.03 | 14.13 | 23.21 | 29.55 | 96.55 | 170.99 |
Operating Income | -3.46 | 1.44 | -7.68 | -17.85 | -84.12 | -166.8 |
Interest Expense | -2.77 | -2.64 | -2.58 | -2.63 | -2.09 | -4.73 |
Interest & Investment Income | 0.01 | 0.02 | 0.02 | 0.03 | 0.09 | 0.02 |
Other Non Operating Income (Expenses) | -1.74 | -0.36 | 0.4 | -1.9 | 33.96 | -33.66 |
EBT Excluding Unusual Items | -7.96 | -1.54 | -9.84 | -22.34 | -52.17 | -205.18 |
Other Unusual Items | 1.93 | 1.93 | 0.98 | 75.34 | -24.49 | - |
Pretax Income | -6.03 | 0.39 | -8.86 | 53 | -76.65 | -205.18 |
Income Tax Expense | 0 | 0 | - | 0.02 | 0.04 | 0.02 |
Earnings From Continuing Operations | -6.03 | 0.39 | -8.86 | 52.98 | -76.7 | -205.19 |
Net Income | -6.03 | 0.39 | -8.86 | 52.98 | -76.7 | -205.19 |
Preferred Dividends & Other Adjustments | 0.13 | 0.12 | 0.11 | 2.98 | 1.32 | 1.05 |
Net Income to Common | -6.16 | 0.27 | -8.97 | 50 | -78.01 | -206.24 |
Shares Outstanding (Basic) | 127 | 124 | 80 | 5 | 0 | 0 |
Shares Outstanding (Diluted) | 127 | 6,422 | 80 | 984 | 0 | 0 |
Shares Change (YoY) | 25.24% | 7926.85% | -91.87% | 211082.03% | 567.40% | 94.93% |
EPS (Basic) | -0.05 | 0.00 | -0.11 | 10.36 | -167.42 | -2953.95 |
EPS (Diluted) | -0.05 | 0.00 | -0.11 | 0.05 | -167.42 | -2953.95 |
Free Cash Flow | -0.26 | -2 | -3.9 | -8.97 | -70.75 | -149.61 |
Free Cash Flow Per Share | -0.00 | - | -0.05 | -0.01 | -151.84 | -2142.80 |
Gross Margin | 76.96% | 77.12% | 80.20% | 64.25% | 73.78% | 50.81% |
Operating Margin | -17.08% | 7.13% | -39.64% | -97.96% | -499.64% | -2023.30% |
Profit Margin | -30.46% | 1.36% | -46.30% | 274.43% | -463.35% | -2501.69% |
Free Cash Flow Margin | -1.27% | -9.89% | -20.14% | -49.25% | -420.21% | -1814.73% |
EBITDA | -3.09 | 1.96 | -7.03 | -17.37 | -83.11 | -165.78 |
EBITDA Margin | -15.26% | 9.70% | -36.29% | -95.34% | - | - |
D&A For EBITDA | 0.37 | 0.52 | 0.65 | 0.48 | 1.02 | 1.02 |
EBIT | -3.46 | 1.44 | -7.68 | -17.85 | -84.12 | -166.8 |
EBIT Margin | -17.08% | 7.13% | -39.64% | -97.96% | - | - |
Effective Tax Rate | - | 0.51% | - | 0.03% | - | - |